Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(6)
MIXED(2)
PROCEDURE(1)
NP137 DL and RP2D
1 trial
phase_1
centre-leon-berard
Pexidartinib
1 trial
phase_1
centre-leon-berard
Trametinib
1 trial
phase_1
centre-leon-berard
Durvalumab
1 trial
phase_1
centre-leon-berard
DEBIO1143
1 trial
phase_1
centre-leon-berard
Scheduled and planned surgery
1 trial
centre-leon-berard
MK2206
1 trial
phase_2
centre-leon-berard
HDM201
1 trial
phase_1
centre-leon-berard

+1 more interventions

9 unique interventions3 categories

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Completed4
Terminated1
Other1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT03871959Phase 1Completed
Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma
Adenocarcinoma of the ColonAdenocarcinoma of the PancreasAdenocarcinoma of the Rectum
PrincipalinvestigatorStart date: 2019-09-15
NCT03714958Phase 1Completed
Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type
Advanced CancerColorectal CancerMetastatic Cancer
PrincipalinvestigatorStart date: 2018-12-20
NCT02977195Phase 1Completed
First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors
Advanced Solid TumorEndometrial CarcinomaHormone Receptor Positive
PrincipalinvestigatorStart date: 2017-01-09
NCT02777710Phase 1Completed
Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers
Advanced CancerColorectal CancerMetastatic Cancer+1 more
PrincipalinvestigatorStart date: 2016-06-01
NCT01466868Phase 2Terminated
Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Diffuse Large B Cell Lymphoma
Principalinvestigator
NCT04274790Withdrawn
Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer
Cancer of ColonMetastasis to Liver
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hervé Ghesquières, MD

Centre Leon Berard, Lyon, France

Related
1 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, Diffuse

Worked with same sponsors:

Centre Leon BerardNational Cancer Institute, France
Collaborated on 1 trial
Similarity Score14%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Metastatic CancerCancer of PancreasColorectal Cancer+1 more
Similarity Score9%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Cancer of PancreasColorectal CancerAdvanced Cancer+1 more
Similarity Score9%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Colorectal CancerMetastasis to LiverCancer of Pancreas
Similarity Score7%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Colorectal CancerCancer of ColonCancer of Pancreas
Similarity Score7%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of ColonColorectal CancerEndometrial Carcinoma
Similarity Score7%

lin shen

Peking University Cancer Hospital & Institute

Related
31 trials

Shared therapeutic areas:

Advanced Solid TumorColorectal CancerCancer of Colon

Worked with same sponsors:

AstraZeneca
Similarity Score7%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Colorectal CancerMetastatic CancerCancer of Colon

Worked with same sponsors:

AstraZenecaMerck Sharp & Dohme LLC+1 more
Similarity Score7%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Metastatic CancerCancer of Pancreas
Similarity Score5%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Cancer of ColonColorectal Cancer
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT03871959Phase 1PrincipalInvestigator

Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma

Adenocarcinoma of the ColonAdenocarcinoma of the PancreasAdenocarcinoma of the Rectum
Completed
NCT03714958Phase 1PrincipalInvestigator

Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type

Advanced CancerColorectal CancerMetastatic Cancer
Completed
NCT02977195Phase 1PrincipalInvestigator

First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors

Advanced Solid TumorEndometrial CarcinomaHormone Receptor Positive
Completed
NCT02777710Phase 1PrincipalInvestigator

Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers

Advanced CancerColorectal CancerMetastatic Cancer+1 more
Completed
NCT01466868Phase 2PrincipalInvestigator

Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma
Terminated
NCT04274790PrincipalInvestigator

Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer

Cancer of ColonMetastasis to Liver
Withdrawn

All 6 trials loaded